tradingkey.logo
搜索

碧迪医疗

BDX
添加自选
153.840USD
-0.640-0.41%
收盘 07/21, 16:00美东报价延迟15分钟
43.91B总市值
38.76市盈率 TTM

关于 碧迪医疗 公司

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

碧迪医疗简介

公司代码BDX
公司名称Becton Dickinson and Co
上市日期Oct 31, 2099
CEOPolen (Thomas E)
员工数量72000
证券类型Ordinary Share
年结日Oct 31
公司地址One Becton Drive
城市FRANKLIN LAKES
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编07417-1880
电话12018476800
网址https://www.bd.com/
公司代码BDX
上市日期Oct 31, 2099
CEOPolen (Thomas E)

碧迪医疗公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
83.06K
-816.87%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
61.16K
+1.80%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
53.67K
-2.14%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
17.21K
+17.46%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.92K
+0.78%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+22.14%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
10.38K
+10.57%
Mr. Gregory J. Hayes
Mr. Gregory J. Hayes
Independent Director
Independent Director
7.15K
+15.35%
Mr. Vitor Roque
Mr. Vitor Roque
Interim Chief Financial Officer
Interim Chief Financial Officer
7.13K
+24.14%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+28.47%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
83.06K
-816.87%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
61.16K
+1.80%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
53.67K
-2.14%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
17.21K
+17.46%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.92K
+0.78%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+22.14%

常见问题

碧迪医疗的前五大股东是谁?

碧迪医疗 的前五大股东如下:Mr. Richard (Rick) Byrd

有多少机构持有碧迪医疗(BDX)的股份?

截至2026Q1,共有2890家机构持有碧迪医疗的股份,合计持有的股份价值约为241.06M,占公司总股份的87.47%。与2025Q4相比,机构持股有所增加,增幅为-46775483.00。

哪个业务部门对碧迪医疗的收入贡献最大?

在2026Q1,Medication Delivery Solutions业务部门对碧迪医疗的收入贡献最大,创收430.00M,占总收入的20.58%。
tradingkey.logo
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有